Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUID-study: driving impairment after abused medicinal drugs in healthy adults
2026-526362-24-00Phase 4Withdrawn
- Sponsor
- University of Copenhagen
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of clonazepam, sodium oxybate, adenosine-5′-monophosphate, pregabalin, gabapentin and 1 more (7 arms), sponsored by University of Copenhagen. Primary endpoint: Standard deviation of lateral position at 2 hours. Planned start Sep 2026; status: withdrawn.
02
Drugs
clonazepamsodium oxybateadenosine-5′-monophosphatepregabalingabapentin
Beyond the preview
Go deeper on 2026-526362-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2026-526362-24-00.